Public-registry site landscape for NCT02423863, a Melanoma study sponsored by Oncovir, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT02423863 (registry record) |
| Sponsor | Oncovir, Inc. |
| Condition(s) | Melanoma; Head and Neck Cancer; Sarcoma; Non-Melanoma Skin Cancers |
| Phase | PHASE2 |
| Listed sites | 5 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT02423863 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →